Cell Medica
Manufactures cellular immunotherapeutics in order to treat cancer and infectious diseases
Cell Medica has raised €99M across 5 funding rounds from 3 investors, most recently a Series B round in Nov 2014. Based in London, UK; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€99M
€99,292,180
Funding rounds
5
Investors
3
distinct backers
Active since
2007-03
latest 2014-11
Funding by year
EUR raised per yearCell Medica — funding by year — interactive chart.
Data table
| Cell Medica — funding by year | |
|---|---|
| 2007 | €3.4M |
| 2009 | €8.5M |
| 2012 | €24M |
| 2014 | €64M |
Signals
High confidenceRaise-next likelihood11
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5 rounds raised
- ▼ Old (20y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-11-01 | Series B | €64M | Imperial Innovations Limited,Invesco Perpetual,Woodford Investment Management | View deal → |
| 2012-07-01 | Other | €24M | — | View deal → |
| 2009-12-01 | Other | €2.0M | — | View deal → |
| 2009-09-01 | Other | €6.6M | — | View deal → |
| 2007-03-01 | Other | €3.4M | — | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData